XML 40 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Financial Instruments Measured at Fair Value (Tables)
6 Months Ended
Jul. 02, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at July 2, 2016:
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
35,980

 
$

 
$

 
$
35,980

Interest rate swaps
 

 
2,252

 

 
2,252

Foreign exchange contracts
 

 
2,139

 

 
2,139

Contingent consideration
 

 

 
(2,522
)
 
(2,522
)
 
 
$
35,980

 
$
4,391

 
$
(2,522
)
 
$
37,849


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2015:
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available-for-sale securities
 
$
41,178

 
$

 
$

 
$
41,178

Interest rate swaps
 

 
711

 

 
711

Foreign exchange contracts
 

 
(738
)
 

 
(738
)
Contingent consideration
 

 

 
(3,889
)
 
(3,889
)
 
 
$
41,178

 
$
(27
)
 
$
(3,889
)
 
$
37,262

Available-for-sale Securities [Text Block]
The fair value of the company's available-for-sale securities is as follows:
 
 
July 2, 2016
 
December 31, 2015
  
 
Marubun
 
Mutual Funds
 
Marubun
 
Mutual Funds
Cost basis
 
$
10,016

 
$
17,485

 
$
10,016

 
$
17,389

Unrealized holding gain
 
3,239

 
5,240

 
8,708

 
5,065

Fair value
 
$
13,255

 
$
22,725

 
$
18,724

 
$
22,454



Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]
The fair values of derivative instruments in the company's consolidated balance sheets are as follows:
 
 
Asset (Liability) Derivatives
  
 
  
 
Fair Value
  
 
Balance Sheet
Location
 
July 2,
2016
 
December 31,
2015
Derivative instruments designated as hedges:
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges
 
Other liabilities
 
$

 
$

Interest rate swaps designated as fair value hedges
 
Other assets
 
2,252

 
711

Foreign exchange contracts designated as cash flow hedges
 
Other current assets
 
77

 
896

Foreign exchange contracts designated as cash flow hedges
 
Accrued expenses
 
(874
)
 
(572
)
Total derivative instruments designated as hedging instruments
 
 
 
1,455

 
1,035

Derivative instruments not designated as hedges:
 
 
 
 

 
 

Foreign exchange contracts
 
Other current assets
 
4,764

 
1,729

Foreign exchange contracts
 
Accrued expenses
 
(1,828
)
 
(2,791
)
Total derivative instruments not designated as hedging instruments
 
 
 
2,936

 
(1,062
)
Total
 
 
 
$
4,391

 
$
(27
)
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effect of derivative instruments on the company's consolidated statements of operations is as follows:
 
 
Gain (Loss) Recognized in Income
  

Quarter Ended

Six Months Ended
  
 
July 2,
2016
 
June 27,
2015
 
July 2,
2016
 
June 27,
2015
Derivative instruments not designated as hedges:
 
 
 
 
 
 
 
 
Foreign exchange contracts (a)
 
$
4,660

 
$
(1,187
)
 
$
1,612

 
$
(379
)
  Total
 
$
4,660

 
$
(1,187
)
 
$
1,612

 
$
(379
)

 
 
Cash Flow Hedges
 
 
Quarter Ended
 
Six Months Ended
 
 
July 2, 2016
 
July 2, 2016
 
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
Effective portion:
 
 
 
 
 
 
 
 
Gain (loss) recognized in other comprehensive income
 
$

 
$
543

 
$

 
$
(534
)
Loss reclassified into income
 
$
(150
)
 
$
(469
)
 
$
(299
)
 
$
(1,091
)
 
 
 
 
 
 
 
 
 
 
 
Cash Flow Hedges
 
 
Quarter Ended
 
Six Months Ended
 
 
June 27, 2015
 
June 27, 2015
 
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
 
Interest Rate Swaps (b)
 
Foreign Exchange Contracts (c)
Effective portion:
 
 
 
 
 
 
 
 
Gain (loss) recognized in other comprehensive income
 
$

 
$
(2,245
)
 
$
827

 
$
437

Gain (loss) reclassified into income
 
$
(141
)
 
$
163

 
$
(302
)
 
$
(678
)
Ineffective portion:
 
 
 
 
 
 
 
 
Gain recognized in income
 
$

 
$

 
$
69

 
$



(a)
The amount of gain (loss) recognized in income on derivatives is recorded in "Cost of sales" in the company's consolidated statements of operations.
(b)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations. The gain (loss) amounts reclassified into income relate to the termination of swaps.
(c)
Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Cost of sales" in the company's consolidated statements of operations.